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Abstract 
Background and Significance: One in 12 Asian and Pacific Islanders (APIs) are infected with hepatitis 
B (HBV). APIs represent one-third of the population in San Francisco. San Francisco Hep B Free 
(SFHBF), a citywide collaboration, works to educate physicians and the community on the importance of 
hepatitis B among APIs through increasing awareness, education and the availability of screening and 
vaccinations. The purpose of this paper was to qualitatively assess the perceived impact of SFHBF on the 
awareness and attitudes of physicians regarding screening and vaccination of APIs. Methods: Twenty 
physicians (n=20) participated in key informant interviews about HBV awareness and involvement with 
SFHBF. The questions focused on physician attitudes and practice towards HBV screening, vaccination 
and follow-up care, communication with patients about HBV, and awareness and effectiveness of the 
SFHBF outreach efforts. Results: Findings highlighted SFHBF’s impact on physicians’ sensitivity and 
awareness. Overall, physicians were increasing their HBV screening and vaccination rates among their 
API patients. Physicians noted the need for continual support to prioritize HBV screening and vaccination 
among their API patients. Conclusion: The findings of this study are important for understanding the 
impact of public health campaigns on physician attitudes and practices regarding HBV education, 
screening, and vaccinations among their API patients. 
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Introduction 
 
Chronic hepatitis B virus (HBV) infection and 
its sequelae – cirrhosis, liver failure, 
hepatocellular carcinoma (HCC), and death – 
disproportionately affect Asian/Pacific Islander 
(API) populations in San Francisco, as well as 
throughout the United States (CDC, 2009). 
Although APIs comprise only 4.5% of the U.S. 
population (US Census, 2010), they account for 
more than 50% of Americans who are living 
with chronic HBV infection (Altekruse, 
McGlynn, & Reichman, 2009) with the highest 
occurrence of HCC occurring in APIs who have 
immigrated to the U.S. (CDC, 2009). The city of 
San Francisco has a higher density of APIs than 
any other U.S. city. APIs represent 32% of the 
city’s population of just over 800,000, many of 
whom are foreign-born, with the majority of 
foreign-born residents coming from areas with 
high (>8%) and intermediate (2-7%) prevalence 
levels for the hepatitis B surface antigen 
(HBsAg) (San Francisco Department of Public 
Health, 2010). APIs in San Francisco are 
disproportionately affected by HBV, as they 
represented an estimated 88% of newly reported 
cases to the SFDPH in 2010 (San Francisco 
Department of Public Health, 2010). Currently, 
San Francisco has the highest rate of liver cancer 
in the U.S. Given that APIs bear the largest 
burden of chronic HBV infection in San 
Francisco, there is a great need to provide 
culturally and linguistically appropriate 
education about HBV prevention throughout the 
Domingo, J.R., Yoo, G.J., Henne, J., Shiau, R., Sanchez, M.A. / Californian Journal of Health Promotion 2016, Volume 10, Issue 3, 
15-25. 
 
 16 
API community. 
Although the Centers for Disease Control and 
Prevention (CDC) recommends that API patients 
born abroad and their children receive testing for 
HBV (CDC, 2014), studies have showed that 
screening and vaccinations among the API 
population are quite low (Lai et al., 2007; 
Nguyen, Gildengorin, Truong, & McPhee, 2007; 
Daley et al., 2009; Foster, Huiming, Kanwal, 
Han, & Speigel, 2011; Mukhtar et al., 2015). 
Physicians play an influential role in screening 
and vaccinating patients, yet studies have shown 
that many physicians fail to screen their patients 
for HBV (Daily et al., 2009; Foster, Huiming, 
Kanwal, Han, & Speigel, 2011; Mukhtar et al., 
2015). A study of family physicians showed that 
less than half of physician respondents were 
likely to support standing orders for HBV 
guidelines/practices for vaccination (Daley, et 
al., 2009). In San Francisco, one study found 
that approximately 43% of physicians were 
unaware of HBV guidelines associated with 
screening and vaccination (Mukhtar et al., 
2015). Another study of physician practice 
behavior at a San Francisco hospital found that 
only 61.5% of patients were tested and that 
47.4% were vaccinated (Nguyen, Gildengorin, 
Truong, & McPhee, 2007). Another study found 
that 65% of Chinese-speaking patients in San 
Francisco had received HBV screening (Lai et 
al., 2007).  
 
Studies on physician practice barriers to HBV 
screenings have noted the lack of disclosure by 
patients of high-risk activity, patient’s lack of 
health care coverage for vaccination/treatment, 
and lack of time in assessing HBV risk factors 
(Daley et al., 2009). Other studies have shown 
that the absence of HBV screening for API 
patients has been due to provider barriers, 
including heavy caseloads and lack of 
prioritization (Mukhtar et al., 2015). Various 
studies have demonstrated the importance of 
comprehensive physician education to raise 
awareness of HBV risk among API patients and 
the need for HBV screening and vaccinations 
(Lai et al., 2007; Nguyen, Gildengorin,Truong, 
& McPhee, 2007; Daley et al., 2009; Foster, 
Huiming, Kanwal, Han, & Speigel, 2011; 
Mukhtar et al., 2015). Studies of physician 
attitudes on HBV and their API patients are 
necessary to bring attention to the need for 
increased training and continuing education on 
HBV prevention, the need for vaccination, and 
practices for morbidity and HBV-related liver 
cancer mortality in APIs. 
 
San Francisco Hep B Free Campaign: SF Bay 
Area Clinician Honor Roll 
In January 2007, the San Francisco Hep B Free 
(SFHBF) campaign, a citywide program, was 
founded as a partnership between Asian Week 
Foundation, the Asian Liver Center at Stanford 
University and the San Francisco Department of 
Public Health (SFDPH). The goal of the 
program was to create public and healthcare 
provider awareness about the importance of 
testing and vaccinating APIs and foreign-born 
individuals for HBV and to overcome gaps in 
knowledge and barriers to screening and care. 
An objective of this effort included encouraging 
clinicians to take a more active role in the API 
community in HBV screening and vaccinating 
(Bailey et al., 2011). The SFHBF campaign’s 
Clinician Honor Roll began in 2008. Through 
the Honor Roll, clinicians pledged to screen at-
risk patients per CDC guidelines (Bailey et al., 
2011). In addition to the Clinician Honor Roll, 
the campaign conducted HBV education for 
providers through Grand Rounds at local 
medical centers, continuing medical education 
(CME), screening algorithms system for patient 
screenings, informational and educational 
sessions for physicians, and distribution of 
patient-initiated screening/vaccination pledge 
forms for physicians. One thousand five hundred 
(1,500) physicians were enrolled in the program 
(SF Hep B Free, 2011). Since 2009, clinicians 
on the Honor Roll have successfully screened 
over 10,000 San Francisco residents for chronic 
HBV (SF Hep B Free, 2013). This paper 
qualitatively assesses physician attitudes 
towards HBV vaccination and screening in API 
patient populations and whether physician 
education efforts conducted by SFHBF were 
considered effective. 
Methods 
 
Participants and Intervention 
In 2013, a purposive sample of key informant 
primary care physicians in San Francisco was 
used to conduct this study. Recruitment and 
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selection were taken from a list of physicians 
from medical groups, centers, and practices 
within San Francisco. Eligibility and inclusion 
criteria of key informants included those with an 
MD working in primary care, those with at least 
seven years of practice, and those working with 
a high percentage (30% or higher) of API 
patients. Because the SFHBF campaign had 
started six years earlier, seven years in practice 
was used as a marker for physicians who may 
have been present in San Francisco to receive 
any intervention from the SFHBF campaign.  
One of the goals of the campaign has been to 
educate health care providers on the importance 
of prioritizing HBV screenings and vaccination 
among their API patients (Table 1).  The 
campaign to educate physicians included 
physician networking and seminars, peer-
developed continuing education trainings and 
grand rounds, and targeted outreach through 
solicitation and engagement through mailed 
materials. Through Clinician Honor Roll, the 
campaign also worked to recognize physicians 
who pledged to screen at-risk patients (See 
Table 1). 
Table 1. 
 
SFHBF Campaign: Physician Education Efforts Timeline 
Year Education Efforts/Exposure Activity 
2006 • SF Board of Supervisors pass Assemblywoman Fiona Ma’s mandate to screen and vaccinate API residents for HBV. SFHBF is founded and commences operations   
2007 
• 150 local community health organizations pledge support for HBV screening and vaccinations 
• 32 health related organizations actively participate in the campaign 
• 230 physicians/health clinicians  reached and become involved at 8 CME events 
2008 
• “B a Hero” media campaign officially commences and is advertised for 3 consecutive months citywide 
• Two physician/ health clinician working groups begin 
• Diagnostic flowchart developed & distributed to physicians/health clinicians  
• SFHBF sponsors CDC press conference on HBV screening recommendations for physicians  
• HBV training, seminars, and grand rounds begin for medical students and residency physicians 
• HBV research on APIs presented at National Immunization Conference, APHA, & B Free CEED  
2009 
• SFHBF Clinician Honor Roll established and 702 physicians/health clinicians are enrolled 
• HBV training, seminars and grand rounds begin for physicians/health clinicians 
• 483 physicians/health clinicians attend 26 educational events 
• 1200 physician/ health clinicians are solicited to enroll in the Clinician Honor Roll 
2010 
• “Which one Deserves to Die” media campaign begins, and features ten physicians  
• SFHBF-involved physicians establish an HBV surveillance tree to report and record cases  
• 100 physician and health clinician enrollees are added to the Clinician Honor Roll  
2011 
• SFHBF admitted as full member to the National Viral Hepatitis Roundtable 
• 967 physicians and health clinicians are solicited to sign up for the Clinician Honor Roll 
• 90 physicians and health clinician enrollees are added to the Clinician Honor Roll  
2012 
• DHHS endorses HBV awareness tools for the API community, for physicians, and health clinicians  
• 308 physicians and health clinician enrollees are added to the Clinician Honor Roll  
• Local API and HBV-related cancer disparities research initiated by SFHBF-involved physicians  
• First HBV CME webinar for Clinician Honor Roll physicians and health clinicians 
• Grand total of 1200 physician/health clinicians on Clinician Honor Roll   
2013 • National Action Plan to End Hepatitis created and disseminated to physicians/health clinicians • Year-end total 1228 physicians and health clinicians on Clinician Honor Roll  
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Measures 
The Henne Group and the SFHBF leadership 
contributed to the development of the questions 
to examine the effectiveness of the methods and 
strategies used by the SFHBF campaign. 
Questions about the following were included: 1) 
screening practices, 2) patient communication 
regarding HBV, and 3) awareness and perceived 
impact of SFHBF and physician outreach 
activities such as the Clinician Honor Roll.  
 
Procedures 
In total, twenty (n=20) primary care physicians 
participated in 30-minute in-depth interviews 
conducted by The Henne Group. Interviews 
were conducted by telephone and were audio-
recorded and transcribed. Qualitative data 
analysis of interview transcripts was performed, 
and major themes were identified. 
 
Results 
 
Physicians who participated in the key informant 
interviews were those working in primary care. 
The ethnic background of the physicians varied 
with the majority being Chinese American 
(40%) and Caucasian (25%). Physicians who 
participated in these interviews had varying 
exposure and knowledge of the SFHBF 
campaign. Tier 1 physicians were those who 
were knowledgeable of SFHBF and active in 
physician education efforts. Tier 2 included 
those who were knowledgeable of SFHBF and 
not active in physician education efforts. Tier 3 
were physicians who were not aware of SFHBF 
and not involved in the campaign.  
 
The majority of physicians (60%, n=12) who 
were exposed to the campaign's advertisements 
or participated in SFHBF physician education 
efforts stated that they increased HBV 
screenings and vaccinations among their API 
patients (see Table 3). As an outcome of 
physician exposure to the campaign, 65% of 
physicians interviewed expressed the need to 
make continual HBV screening and vaccination 
a priority (see Table 3). 
 
 
Table 2. 
Background of Key Informant Physicians (n=20) 
 N (%) 
Ethnicity   
      Chinese American 8 (40.0) 
      Caucasian 5 (25.0) 
      Asian Indian 2 (10.0) 
      Malaysian 1 (5.0) 
      Vietnamese American 1 (5.0) 
      Unknown 3 (15.0) 
Level of Involvement in SFHBF  
      Tier 1 (High Exposure/Active) 5 (25.0) 
      Tier 2 (Exposure, Low/non-Active) 5 (25.0) 
      Tier 3 (No exposure/activity) 10 (50.0) 
 
Differences did exist though based on the level 
of exposure and involvement with SFHBF 
physician education efforts. Physicians who 
were more exposed (Tier 1 and Tier 2) to 
SFHBF physician education efforts were more 
likely to screen and vaccinate their API patients. 
 
 
SFHBF Mass Media Campaign: Heightened 
Physician Awareness and Sensitivity 
Fifteen of the interviewed physicians (75%) felt 
that SFHBF efforts raised awareness on the 
importance of screening and vaccinations among 
API patients (Table 3). Physicians mentioned 
that they communicated with more of their API 
patients who raised concerns regarding HBV as 
a result of the information that they had seen on 
buses or TV commercials.
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Table 3. 
 
Themes regarding Physician Attitudes and Practices towards 
HBV Vaccination and Screening in API Patient Populations (n=20) 
Theme Tier 1 (n=5) Tier 2 
(n=5) 
Tier 3  
(n=10) 
Total N (%) 
(n=20) 
SFHBF campaign heightened physician awareness and  
sensitivity 
5 (100%) 4 (80%) 6 (60%) 15 (75%) 
SFHBF physician education efforts contributed to 
increase in their  HBV screening and vaccinations 
5 (100%) 5 (100%) 2 (20%) 12 (60%) 
Physician need: Need continual support for HBV 
screening prioritization 
5 (100%) 5 (100%) 3 (30%) 13 (65%) 
 
From 2008 to 2009, the “B a Hero” public 
awareness campaign used a playful awareness 
approach to engage individuals utilizing 
“Superman” like imagery of HBV 
screened/vaccinated API community members. 
In 2010, the “Which one deserves to die?” 
campaign commercials and visual 
advertisements featured every day, local Asian 
Americans including ten intramural basketball 
players, ten pageant contestants, ten family 
members, and ten practicing physicians and the 
statement that one in ten were at risk for HBV, 
liver cancer and death. The majority of 
interviewed physicians reacted positively and 
discussed seeing the advertisements and the 
televised public service announcements in both 
mainstream channels and Asian language 
television. Physicians felt the portrayals were 
realistic and showed that HBV was a real threat 
to the health of APIs. 
 
Physicians felt that the campaign’s efforts to 
target the API community contributed to an 
increase in their API patients seeking HBV 
screening and vaccinations. Some interviewed 
physicians discussed the importance of tailoring 
HBV awareness, screening, and vaccination 
efforts to APIs by being language specific and 
also targeting this messaging at API cultural 
festivals like the Asian Lunar New Year 
Celebrations and other festivities such as the 
Asian Heritage Street Festival; Major League 
Baseball home games with the San Francisco 
Giants/Oakland A’s; National Basketball 
Association home games with the Golden State 
Warriors; culturally specific events such as 
Filipino Pistahan and Pista Sa Ngayon; and 
Chinese Harvest Moon Celebrations. Another 
physician discussed that her patients were 
provoked to take action through messaging in 
their native language with a focus on family and 
community vulnerability. Due to widespread 
advertising throughout San Francisco, one 
physician noted how this advertising has 
increased awareness: 
 
I have seen billboards with beauty 
pageants; I mean that was pretty eye-
catching. So maybe since Asians have a 
higher prevalence of hepatitis B, maybe 
more advertisements in their native 
language would help too….and people 
are much more open to that when they 
clearly have read about it or seen the 
billboard and understand what you’re 
talking about. So my guess is it tends to 
create a much more receptive patient for 
a test when it’s offered. 
 
In addition to patients being motivated to discuss 
HBV with their physicians as a result of the 
SFHBF mass media campaign, the majority of 
interviewed physicians also noted that patients 
were also requesting to be screened. 
 
Tier 3 physicians who were not actively 
involved or exposed to the SFHBF campaign 
recall their patients asking to be screened and 
vaccinated against HBV subsequent to the 
advertising. Several physicians noted the 
effectiveness of the SFHBF campaign in raising 
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awareness among their API patients and noted 
patient requests being made for screening and 
vaccination. One physician stated: 
 
Well, it’s pretty good in terms of 
increasing the awareness and making 
everybody in the City aware of hepatitis 
B. So everybody kind of wants to be 
treated and tested and screened. (sic) 
 
Another physician stated: 
 
It’s usually the Chinese patients who are 
bringing it up — I just say we have 
blood tests to find out whether —there 
are different kinds of hepatitis... We can 
test your blood for it to find out if you 
have it. (sic) 
 
Physicians believed that the “Which one 
Deserves to Die?” campaign established the 
seriousness of HBV and a need for HBV 
dialogue within API communities. The 
widespread commercial messaging targeting 
APIs captured the attention of physicians who 
through this campaign became more aware of 
the seriousness of HBV and their own 
capabilities for prevention and treatment. 
Moreover, the SFHBF campaign also 
encouraged APIs to talk to their doctors with 
regard to HBV risk, screening and vaccination. 
 
SFHBF Physician Education Efforts: 
Increased HBV Screening and Vaccinations 
 
Twelve (60.0%) physicians mentioned that 
physician education efforts, whether it be the 
Clinician Honor Roll, working groups, 
community action collaborative, and various 
continuing education seminars and trainings, 
contributed to an increase in HBV screening and 
vaccinations in their patients(Table 1). In 
addition, several physicians formed a working 
group to produce a series of diagnostic 
flowcharts for HBV screening and vaccinations, 
to develop screening assessment definitions and 
interpretations, and to develop a reference guide 
for HBV/liver cancer misconceptions. Also, 
participating physicians were involved in a 
community action collaborative with non-
healthcare organizations, aligning screening and 
vaccination programming into their activities. 
Several interviewed physicians worked with 
SFHBF in creating continuing education 
activities and trainings, as well as symposiums 
related to reducing HBV-related disparities, 
clinician guidelines for screening and diagnosing 
HBV/liver cancer, and public 
health/epidemiological insights. Differences did 
exist among physicians who were involved in 
SFHBF physician efforts and those who were 
not. Those involved (Tier 1 and Tier 2) were 
active in performing HBV screenings and 
vaccinations among APIs. Physicians unaware 
and not involved (Tier 3) in the SFHBF 
campaign tended not to prioritize HBV 
screenings and vaccinations among their API 
patients. Overall, all physicians moderately and 
actively involved with SFHBF were actively 
screening and vaccinating their API patients 
(Table 3). 
 
Prior to the 2010 “Which one Deserves to Die?” 
Campaign, physicians who were involved in the 
SFHBF campaign estimated that they did one to 
two screenings per month, and after the 
campaign, they conducted screenings regularly, 
three to four times a week. An involved (Tier 1) 
physician credits the SFHBF campaign and 
describes how he is now more comfortable with 
screening and vaccinating his API patients: 
 
I have been attending more and more 
hepatitis B programs on a regular basis. 
And as I'm more familiar with this 
condition and also more familiar with 
the medication used to treat hep B, I'm 
becoming more comfortable following 
and treating patients with hepatitis B. 
(sic) 
 
In addition to increased awareness, physicians 
involved in SFHBF activities discussed how the 
campaign enhanced patient-provider 
communications around HBV. All physicians 
who were involved with the campaign noted that 
they were more sensitive to initiating the topic in 
conversations with API patients who became 
aware of HBV through the “Which one Deserves 
to Die?” campaign and wanted to consider HBV 
screening and vaccination. These physicians 
responded by encouraging their patients to be 
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screened and vaccinated. 
 
Interviewed physicians stated that the SFHBF 
campaign’s advertisements and their own 
involvement with SFHBF contributed to an 
increase in screenings and vaccinations. As a 
result of the SFHBF physician education efforts 
and widespread targeting of APIs, these 
physicians noted heightened concern among 
their patients that allowed opportunities for 
physician-patient dialogue to discuss HBV 
transmission, screenings, and the need for 
vaccination. The Clinician Honor Roll and 
pledge form provided an opportunity for non-
active physicians to become involved with 
SFHBF through a commitment to 
screen/vaccinate their API patients according to 
CDC Guidelines (SF Hep B Free, 2009). Upon 
receiving the pledge form, physicians were 
solicited offers of continuing/professional 
development incentives (e.g. CME credits) 
through attendance at trainings and participation 
in creating practice-based programming or 
evidence-based systems (e.g., flow charts, 
diagnostic tools, clarification guidelines). A 
physician moderately involved (Tier 2) with 
SFHBF stated how he has become more 
comfortable with screening: 
 
And I guess it’s a bigger impact 
[”Which One Deserves to Die?” 
campaign] becoming more aware and 
understand this disease through fear; I 
am more comfortable screening and 
vaccinating patients at risk for hep B. 
[sic] 
 
Another moderately involved (Tier 2) physician 
stated: 
 
I’m pretty comfortable, because I have 
been attending some conferences, and I 
read, you know, materials, and I try to 
keep myself updated with the 
recommendation and the treatment. And 
since becoming involved, I pretty much 
universally screen because I figure I 
could then prevent, you know, make 
sure they’re vaccinated against hep B or 
refer them to treatment. [sic] 
 
These responses reflect the success of SFHBF 
physician education efforts. In addition, 
physicians encouraged other physicians to attend 
such events. Physicians’ involvement in these 
activities have meant that those working with 
API patients are much more aware of the need 
for dialogue with their patients regarding risk, 
screening, and vaccinations. Because of their 
involvement in SFHBF, many of the interviewed 
physicians felt a stake in their patients’ lives 
through providing medically correct education 
about HBV and de-stigmatizing HBV through 
educating patients about the benefits of being 
screened and vaccinated. 
 
Physician Need: Continual HBV Screening 
Prioritization 
 
Sixty-five percent of physicians (65%, n=13) 
discussed the need to make HBV screening and 
vaccination a priority among their API patients 
(see Table 3). However, all of the interviewed 
physicians discussed the competing demands 
within their practice that sometimes prevented 
them from making this a priority. Moreover, 
physicians are overloaded with information so 
there is a tendency to address what needs their 
immediate attention. Among their API patients, 
co-morbidities such as cardiovascular disease, 
hypertension, and diabetes were health care 
issues that often took precedence. All of the 
physicians acknowledged the difficulties in their 
practice that prevent comprehensively screening 
their API patients for HBV. One physician 
stated: 
 
If they come in and tell you that they 
have for instance a history of heart 
attacks, then you’ll be focusing more on 
other cardiovascular risk factors and 
stuff before you actually get to talking 
about hepatitis. But if they have a ton of 
other bigger problems, then you’ll 
probably be dealing with all that before 
you deal with screening for hepatitis. 
(sic) 
 
Physicians noted they were overwhelmed with 
competing health demands and that they are 
inundated with information regarding other 
diseases which makes prioritization difficult. 
Domingo, J.R., Yoo, G.J., Henne, J., Shiau, R., Sanchez, M.A. / Californian Journal of Health Promotion 2016, Volume 10, Issue 3, 
15-25. 
 
 22 
One physician noted: 
 
Every doctor gets probably a hundred 
things a week of guidelines and 
recommendations and latest update from 
the American Academy of Family 
Physicians or the American College of 
Physicians or this drug company or this 
hospital or this firm or this latest 
SFDPH guideline for the outbreak of 
Norwegian scabies or this or that. And it 
all just goes into the big circular file. 
Everybody is just overloaded with 
information, doing what they can to just 
keep up. 
 
Because of other competing health concerns, 
physicians mention not prioritizing HBV as a 
risk in their API patients. Most of the physicians 
believed that in order for HBV to be a priority, 
education and awareness directed towards 
physicians needs to be consistent through 
continuing medical education (CME). One 
physician stated: 
 
Public campaigns intended to raise 
awareness of the community, of the 
public—that works. CME has—and 
there’s tremendous data in the scientific 
literature about the effectiveness of 
CME anyway in raising provider 
knowledge from a standpoint of 
continuing medical education. We do it. 
It does contribute. It does add some 
value. But and again the data 
scientifically doesn’t support that being 
an effective modality to change 
physician behavior. To some degree it 
does. (sic) 
 
Despite being burdened by competing demands, 
physicians believe with the right information, 
tools, and reports to remind physicians of the 
susceptibility of HBV among their API patients 
that they could see an increase in HBV 
screenings and vaccinations. Several physicians 
recommended that a prompt to screen and 
vaccinate their API patients in their electronic 
medical records would be useful. They 
suggested that health record prompts in 
electronic medical records, especially with high-
risk and under screened patients, would help 
with making HBV screenings and vaccinations a 
priority. One physician noted: 
 
If you have an electronic medical record 
and you get a prompt saying ‘Oh, the 
Asian patient here Mr. Wong, you’re 
going to see no record of hepatitis B 
screening. You want to order that 
today.’ Or you get a quarterly report that 
says ‘Here’s your key quality statistics 
and you’ve only screened 20% of your 
at-risk patients for hepatitis B.’ Or you 
have twelve patients with chronic 
hepatitis B and only six of them had 
liver tests checked in the last year. (sic) 
 
Physicians pointed out that information and 
awareness is needed and must be sustainable and 
long-term. Thus, screening and vaccination must 
be built into the quality infrastructure of the 
practice.  
 
Discussion 
 
In response to SFHBF campaign efforts to 
educate the API community and physicians, this 
study has shown qualitatively how physicians’ 
attitudes may have been impacted through 
awareness and involvement in this campaign. 
The three key findings include the following 
physician perceptions: 1) the SFHBF mass 
campaign contributed to a heightened sensitivity 
and awareness among these interviewed 
physicians in terms of HBV screenings and 
vaccinations for API patients 2) SFHBF 
physician education efforts contributed to 
increased screening and vaccination of API 
patients among these physicians and 3) there is 
the continual need to make HBV screening and 
vaccination a priority among their API patients. 
SFHBF provided a multi-faceted approach to 
educating physicians through such methods as 
the Clinician Honor Roll and continuing 
education, as well as educating the API 
community. 
 
As demonstrated, the exposure and involvement 
of the interviewed physicians with SFHBF 
correlated with their sense of the importance to 
communicate the importance of HBV screening 
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and vaccination with their patients. Moreover, 
those actively and moderately involved with 
physician education efforts all had incorporated 
HBV screening and vaccination into their 
current practice. Past studies of physicians who 
take on new practice protocol are often known 
as “early physician adopters” who then share 
their education through professional networks 
(Coleman, Menzel, & Katz, 1959). In the 
SFHBF campaign, physicians involved with the 
campaign embraced the strategy that screening 
and vaccination among API patients could 
reduce morbidity and mortality for those at risk. 
Like other studies have suggested (Daley et al., 
2009; Sheu, Toy, Kwahk, Yu, Adler, & Lai, 
2010; Yoo, Dariotis, Fang, & Zola, 2011; Foster, 
Huiming, Kanwal, Han, & Spiegel, 2011; 
Mukhtar et al., 2015), results of this study 
indicate that participating in HBV continuing 
medical education and in other educational 
activities allowed for increased knowledge and 
greater sensitivity about the importance of HBV 
screening and vaccination for their API patients.  
 
While participants discussed the competing 
demands on physicians’ time and the need for 
prioritization of HBV screening and vaccination 
among their API patients, the physicians we 
interviewed concurred with the effectiveness of 
integrating HBV screening into electronic 
medical records (EMR). In previous studies, 
physicians alluded to the utilization of electronic 
medical records as an effective method to 
increase HBV screening among their high-risk 
patients (Coleman, Halas, Peeler, Casaclang, 
Williamson, & Katz, 2015). As mentioned in the 
interviews, physicians felt that EMRs could be 
used as a tool to inform physicians about a 
patient's prior HBV risk history and to identify 
the patient’s HBV screening and vaccination 
history, and/or history of HBV 
infection/treatment. As physicians stated in the 
study, health care infrastructures could assist 
physicians, through EMRs, in prioritizing their 
patient’s needs; especially their API patients. 
 
Limitations 
There are several limitations of this study, such 
as sampling and qualitative data collection 
methods that make this study non-generalizable 
to clinicians nationwide. First, the sample was a 
non-random, purposive sample of primary care 
physicians that did not include physician 
assistants (PAs) as well as nurse practitioners 
(NPs), who also interact with patients in a 
primary care setting and could benefit from 
similar clinician interventions to increase HBV 
awareness and the need for screening and 
vaccination among their patient population. 
Also, this was a cross-sectional study of 
physicians, and, thus, the study cannot conclude 
whether the physicians’ attitudes and practices 
over time were due to SFHBF physician 
outreach efforts. Finally, this qualitative study 
solely relies on physicians’ open-ended 
responses. In order to determine whether 
physician attitudes and practice behaviors 
changed as a result of the interventions, a 
medical record review of HBV-related 
interventions conducted on a cohort of API 
patients over time would be a useful follow-up 
project that could further shed light on the key 
findings identified from this purposive physician 
sample. 
 
Implications 
The SFHBF campaign and the involvement of 
local physicians appears to be a framework that 
can be useful in increasing physician awareness 
and sensitivity regarding HBV and API patients. 
A multi-faceted HBV campaign that outreaches 
to both the community and physicians with 
cultural relevance and thematic engagement can 
be beneficial for all involved. Public health 
campaigns should aim to increase conversations 
regarding HBV screening and vaccinations 
between physicians and patients. Additionally, 
with any campaign effort to increase screening, 
the campaign should be aware of the need to 
help physicians to prioritize HBV screening and 
vaccinations of their API patients through 
traditional physician education efforts, as well as 
technological solutions. Our findings indicate 
that primary care physicians would be very 
receptive to the idea of having electronic 
medical records notify the physician of the need 
to screen and vaccinate patients at high-risk for 
HBV. Similarly, continuing medical education 
efforts allow physicians to have the latest 
information and necessary public health tools 
and resources to support screening and 
vaccinating against HBV, as well as for follow-
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up for those chronically infected. Behavior 
change among physicians and practice 
adaptation can occur but requires a constant 
continuum of education and promotion among 
physicians and within health care infrastructures. 
Ongoing, widespread public health campaigns 
such as “Which one Deserves to Die?” and joint 
physician education efforts to increase 
sensitivity and raise awareness of the importance 
of prioritizing HBV screening and vaccinations 
among their API patients will ultimately 
contribute to the reduction of morbidity and 
mortality for this population. 
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